1. Home
  2. GERN vs AVO Comparison

GERN vs AVO Comparison

Compare GERN & AVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geron Corporation

GERN

Geron Corporation

HOLD

Current Price

$1.10

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Mission Produce Inc.

AVO

Mission Produce Inc.

HOLD

Current Price

$11.69

Market Cap

1.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GERN
AVO
Founded
1990
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
GERN
AVO
Price
$1.10
$11.69
Analyst Decision
Buy
Strong Buy
Analyst Count
5
4
Target Price
$4.25
★ $16.50
AVG Volume (30 Days)
★ 5.9M
922.9K
Earning Date
11-04-2026
09-08-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.85
1.92
EPS
★ N/A
N/A
Revenue
$1,065,000.00
★ $1,391,200,000.00
Revenue This Year
$28.49
$4.60
Revenue Next Year
$44.73
$16.03
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 12.68
52 Week Low
$1.04
$10.07
52 Week High
$2.01
$15.53

Technical Indicators

Market Signals
Indicator
GERN
AVO
Relative Strength Index (RSI) 32.01 39.15
Support Level $1.08 $10.22
Resistance Level $1.26 $13.35
Average True Range (ATR) 0.05 0.49
MACD -0.00 -0.04
Stochastic Oscillator 8.33 38.41

Price Performance

Historical Comparison
GERN
AVO

About GERN Geron Corporation

Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.

About AVO Mission Produce Inc.

Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.

Share on Social Networks: